Competition & Peer Data API & CSV Delivery

Arbor Rapha Capital Bioholdings I's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Arbor Rapha Capital Bioholdings I (ARCK) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2022
Competitors Tracked
7
Publicly traded peers
Peer Group Market Share
-
Share of combined sales, Q3 2022
Revenue Growth Y/Y
-
Peers: 35.48 %
Net Margin
-
Peers: 0.43 %

Key Findings: Arbor Rapha Capital Bioholdings I vs Its Competitors

  • TTM: Trailing 12-month revenue of 17M vs 42,329M combined for tracked competitors (0.0% combined share).

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/ARCK/competitors
https://api.csimarket.com/api/v1/companies/ARCK/relationships
https://api.csimarket.com/api/v1/companies/ARCK/similar
Programmatic access for models, analytics, and integration workflows.

Arbor Rapha Capital Bioholdings I vs. its Competitors, Q3 2022

TTM net margin

Arbor Rapha Capital Bioholdings I -6.0 %
Competitors combined +0.9 %

TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in an SEC filing; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.

Competitor Financial Benchmarking - TTM Commercial

TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Arbor Rapha Capital Bioholdings I and its 4 competitor groupings. Available under Commercial License.

Entity TTM Revenue Latest Q ×4 Rev Run-rate vs TTM TTM Net Income TTM Net Margin
Arbor Rapha Capital Bioholdings Corp I $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitors combined $12,345M $12,345M +12.3% · Accelerating $1,234M 12.3%
Competitor Financial Benchmarking

TTM revenue, run-rate and net margin benchmarking across Arbor Rapha Capital Bioholdings I's competitor groups requires a Commercial License.

Arbor Rapha Capital Bioholdings I's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Arbor Rapha Capital Bioholdings Corp I - - - Yes
Competitors combined (7) 71% 71% 14% 40%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

ARCK Stock Performance relative to its Competitors

ARCK Competitors (weighted) Percent change over the selected range

Arbor Rapha Capital Bioholdings I's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
50%beat U.S.A. 500
Competitors Combined
(2 of 4)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Arbor Rapha Capital Bioholdings Corp I - -
Competitors combined (4) 40.4% 63.2%
High-Confidence Competitors (0) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Arbor Rapha Capital Bioholdings I's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

5 Best-Performing Tracked Competitors, Trailing 12 Months

#CompetitorTTM Share Price Returnvs U.S.A. 500
1 Ngl Energy Partners Lp 282.9% Outperformed
2 Delek Us Holdings Inc 282.9% Outperformed
3 Crossamerica Partners Lp 282.9% Outperformed
4 Global Partners Lp 282.9% Outperformed
Best-Performing Competitor Returns

TTM share price return and U.S.A. 500 outperformance for Arbor Rapha Capital Bioholdings I's best-performing tracked competitors requires a Commercial License.

Source: CSIMarket API, trailing 12 months.

Publicly Traded Peers of Arbor Rapha Capital Bioholdings Corp I

Revenue and income for trailing 12 months, in millions of $, except employees
Company Market Cap Revenues Income Employees
Arbor Rapha Capital Bioholdings Corp I 84.86 17.45 -1.05 -
Delek Us Holdings Inc 4,215.95 12,056.50 281.10 1,902
Crossamerica Partners Lp 827.41 2,413.36 55.25 3,047
Macquarie Infrastructure Holdings Llc 367.53 480.12 2,681.71 3,600
Adams Resources and Energy Inc 97.72 2,784.46 -8.14 741
Patriot Transportation Holding Inc 58.44 94.79 2.67 220
SUBTOTAL 5,651.92 42,826.85 3,078.02 14,779
2 more competitors available

Sign in to see all competitors of Arbor Rapha Capital Bioholdings Corp I.

Sources: Arbor Rapha Capital Bioholdings Corp I's official press releases and regulatory filings; CSIMarket.com's market research; and the financial filings and press releases of the other companies cited.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Arbor Rapha Capital Bioholdings Corp I versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.

Arbor Rapha Capital Bioholdings I's Business Segment Mix vs Peers

Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).
Company Largest Segment 2nd Segment 3rd Segment
Delek Us Holdings Inc Refining 95.07 % Logistics 4.93 % -
Adams Resources and Energy Inc Crude oil marketing 95.06 % Transportation 3.14 % Logistics and repurposing 1.95 %
Ngl Energy Partners Lp Crude Oil Logistics 44.39 % Liquids Logistics 29.90 % Water Solutions 25.69 %
Global Partners Lp Wholesale segment 71.69 % Gasoline Distribution and Station Operations segment 22.86 % Commercial segment 5.45 %

Source: operating segment revenue as reported in each company's SEC filings (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).

Arbor Rapha Capital Bioholdings I's Productivity vs Peers Comparison

Revenue and income per employee, trailing 12 months, in $; market cap in millions of $
CompanyMarket CapRevenue / EmployeeIncome / Employee
Arbor Rapha Capital Bioholdings Corp I 85 - -
Delek Us Holdings Inc 4,216 6,338,854 147,792
Crossamerica Partners Lp 827 792,046 18,133
Macquarie Infrastructure Holdings Llc 368 133,365 744,919
Adams Resources and Energy Inc 98 3,757,702 -10,987
Patriot Transportation Holding Inc 58 430,841 12,150
PEERS TOTAL 5,567 2,896,637 208,341
2 more Peers available

Sign in to see all peers for Arbor Rapha Capital Bioholdings Corp I.

Arbor Rapha Capital Bioholdings I's Valuation vs Competitive Position

Valuation multiples vs the Blank Checks industry average (68 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns.
Metric Company Industry Average Difference
P/E - 45.2x -
EV / EBITDA - 26.4x -
P/B -25.5x 6.7x -32.2x
Return on Equity - industry aggregate -
Return on Invested Capital - 0.96 % (avg) -

Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.

Arbor Rapha Capital Bioholdings I's SWOT

Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.

Strengths

No rule matched.

Weaknesses

  • Piotroski F-Score of 2 or below, the standard financial-distress signal.

Opportunities

  • Industry revenue growing at a healthy 27.5% median pace.
  • A meaningful share of tracked competitors (40.00 %) show financial-distress signals, a possible opening to gain share.

Threats

No rule matched.

Methodology: mechanical, rule-based SWOT. Each bullet reuses a figure already sourced and cited elsewhere on this page; nothing here is generated narrative or independent analyst judgment.

Arbor Rapha Capital Bioholdings I's Financial Strength vs Peers Comparison

Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months
CompanyQuick RatioWorking CapitalDebt / EquityAsset Turnover
Arbor Rapha Capital Bioholdings Corp I 0.05 0.27 - 1.01
Delek Us Holdings Inc 0.21 0.80 7.45 1.66
Crossamerica Partners Lp 0.03 0.74 - 2.44
Macquarie Infrastructure Holdings Llc 1.06 1.14 0.50 0.25
Adams Resources and Energy Inc 0.15 1.07 0.20 7.67
Patriot Transportation Holding Inc 0.90 2.44 - 1.89
2 more Peers available

Sign in to see all peers for Arbor Rapha Capital Bioholdings Corp I.

Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.

Arbor Rapha Capital Bioholdings I's Revenue and Income Growth vs Peers

Quarterly revenue and net income growth, year over year and quarter over quarter
CompanyPeriodRevenue Y/YRevenue Q/QIncome Y/YIncome Q/Q
Arbor Rapha Capital Bioholdings Corp IQ3 2022+64.8 %-3.5 %--
Delek Us Holdings Inc Q2 2026+47.8 %+54.0 %--
Crossamerica Partners LpQ2 2026+24.1 %+620.7 %-17.3 %+95.3 %
Macquarie Infrastructure Holdings LlcQ1 2022-74.0 %+9.8 %-17.0 %-
Adams Resources and Energy Inc Q3 2024-8.6 %-3.2 %--
Patriot Transportation Holding Inc Q3 2023+5.8 %-0.1 %+11.9 %-55.7 %
PEERS TOTAL+38.2 %+40.0 %+670.9 %-
2 more Peers available

Sign in to see all peers for Arbor Rapha Capital Bioholdings Corp I.

Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.

Arbor Rapha Capital Bioholdings I's Peers' Costs of Sales and Capital Expenditures

Context for revenue growth: peer costs and capex, year over year and quarter over quarter
CompanyPeriodCosts Y/YCosts Q/QCapex Y/YCapex Q/Q
Arbor Rapha Capital Bioholdings Corp IQ3 2022+68.8 %+1.6 %+254.5 %+148.6 %
Delek Us Holdings Inc Q2 2026+37.2 %+33.7 %+5.2 %-8.5 %
Crossamerica Partners LpQ2 2026+23.8 %+1,468.0 %-37.1 %+117.5 %
Macquarie Infrastructure Holdings LlcQ1 2022-51.4 %-29.1 %-68.3 %+27.5 %
Adams Resources and Energy Inc Q3 2024-7.5 %-2.8 %--
Patriot Transportation Holding Inc Q3 2023+343.0 %+7.7 %+37.0 %-30.7 %
2 more Peers available

Sign in to see all peers for Arbor Rapha Capital Bioholdings Corp I.

Arbor Rapha Capital Bioholdings I's Returns and Turnover vs Peers

ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover
CompanyROAROIROEReceivables TurnoverInventory Turnover
Arbor Rapha Capital Bioholdings Corp I---118.7722.96
Delek Us Holdings Inc 3.87%6.58%65.49%15.4313.08
Crossamerica Partners Lp5.60%5.68%-75.2731.74
Macquarie Infrastructure Holdings Llc140.81%157.20%387.09%14.1617.51
Adams Resources and Energy Inc ---16.73107.73
Patriot Transportation Holding Inc 5.34%6.72%8.07%16.0219.67
2 more Peers available

Sign in to see all peers for Arbor Rapha Capital Bioholdings Corp I.

ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).

Arbor Rapha Capital Bioholdings I's Valuation vs Peers

P/E, price to sales, PEG, price to cash flow and price to book
CompanyP/EPrice / SalesPEGP/CFPrice / Book
Arbor Rapha Capital Bioholdings Corp I-4.86-487.45-
Delek Us Holdings Inc 18.790.35-321.839.97
Crossamerica Partners Lp15.760.340.10--
Macquarie Infrastructure Holdings Llc0.130.77--0.59
Adams Resources and Energy Inc -0.04-9.181.15
Patriot Transportation Holding Inc 21.680.62--1.70
PEERS AVERAGE1.840.13-3.08
2 more Peers available

Sign in to see all peers for Arbor Rapha Capital Bioholdings Corp I.

P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.